Ragnar Hovland

Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity

Christian Gløgård, Gry Stensrud, Ragnar Hovland et al. · International Journal of Pharmaceutics · 2002 · 100 citations

Lipid Preparation, Biochemistry, Incorporation Efficacy +5

Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-[12] derivative; a micellar MRI contrast agent

Ragnar Hovland, Christian Gløgård, Arne J. Aasen et al. · Organic & Biomolecular Chemistry · 2003 · 60 citations

Gadolinium DO3A derivatives mimicking phospholipids; preparation and in vitro evaluation as pH responsive MRI contrast agents

Ragnar Hovland, Christian Gløgård, Arne J. Aasen et al. · Journal of the Chemical Society Perkin Transactions 2 · 2001 · 57 citations

Proteinlipid Interaction, Gadolinium Do3a, Derivatives +14

Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to a Clinical Candidate Dimethylpyrazinecarboxamide Phenylcyclohexylacetic Acid (AZD7687)

Jonas G. Barlind, Udo Bauer, Alan M. Birch et al. · Journal of Medicinal Chemistry · 2012 · 36 citations · Full text

Pharmaceutical Science, Candidate Drug, Pyrazinecarboxamide Dgat1 Inhibitors +17

Synthesis and physicochemical characterisation of new amphiphilic gadolinium DO3A complexes as contrast agents for MRI

Christian Gløgård, Ragnar Hovland, Sigrid L. Fossheim et al. · Journal of the Chemical Society Perkin Transactions 2 · 2000 · 35 citations

Contrast Agents, Engineering, Imaging Agent +16